About Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Écully, France
Year Founded
2015
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
amolytpharma.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $140,000,000 · Series-B
Backed by Intermediate Capital Group
- Capital Raise
Raised $80,000,000 · Series-B
Backed by Sectoral Asset Management
- Capital Raise
Raised $74,000,000 · Series-A
startupintros.com
- Milestone
Company founded
Écully, France
Investors & Backers
Intermediate Capital Group
Lead
Sectoral Asset Management
Lead
Andera Partners
Bpifrance
Credit Agricole Entreprises
CTI Life Sciences Fund
EQT Life Sciences
Eurazeo
Kurma Partners
Mass General Brigham Ventures
Novo Ventures
OrbiMed
Pontifax
Sham
Sofinnova Partners
Tekla Capital Management
Turenne Capital
Funding History
Series-B equity
· Jan 6, 2023
Round backers: Intermediate Capital Group
$140,000,000 startupintros.com
Series-B equity
· Sep 1, 2021
Round backers: Sectoral Asset Management
$80,000,000 startupintros.com
Series-A equity
· Jul 1, 2019
$74,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026